Ergoteles’s Rockwell Medical RMTI Stock Holding History

Ergoteles’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,554	Closed	-$102K	–	1540
2021 Q3	$102K	Sell	1,554 -59	-4%	-$4.48K	﹤0.01%	1103
2021 Q2	$161K	Buy	+1,613	New	+$166K	﹤0.01%	1338

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles's RMTI Position: Q4 2021 in Review

Ergoteles sold out of Rockwell Medical (RMTI) in Q4 2021, closing a stake of 1,554 shares — an estimated $102K sold.

Ergoteles first reported a position in RMTI in Q2 2021 and held it in 2 quarters. The position peaked at $161K in Q2 2021. 62 funds tracked by Wall St. Rank hold RMTI as of Q4 2021.

Ergoteles reported no remaining Rockwell Medical position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 1,554 Rockwell Medical shares in Q4 2021, an estimated $102K.
Ergoteles first reported a position in Rockwell Medical in Q2 2021 and held it in 2 quarters.
Ergoteles's Rockwell Medical position peaked at $161K in Q2 2021.
62 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.